Johannesburg – over the past days and weeks, there have been widespread reports from various State Clinics, in certain provinces, that patients have been unable to access supplies of TDF, a key ARV, used primarily in first line HIV treatment. Due to the negative consequences on both patients and the sustainability of South Africa’s Public… Continue reading Update on the reported key anti-retroviral (ARV) Tenofovir (TDF) public sector supply shortages
Aspen is in a closed period from 1 January until the publication of our interim results on the JSE SENS platform to be released on 4 March 2024.
